These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24781800)

  • 1. Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection.
    Lüth S; Fründt TW; Rösch T; Schlee C; Lohse AW
    JAMA Intern Med; 2014 Jun; 174(6):1003-5. PubMed ID: 24781800
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
    Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
    N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
    Braune SA; Wichmann D; von Heinz MC; Nierhaus A; Becker H; Meyer TN; Meyer GP; Müller-Schulz M; Fricke J; de Weerth A; Hoepker WW; Fiehler J; Magnus T; Gerloff C; Panzer U; Stahl RA; Wegscheider K; Kluge S
    Crit Care Med; 2013 Jul; 41(7):1702-10. PubMed ID: 23660733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.
    Vonberg RP; Höhle M; Aepfelbacher M; Bange FC; Belmar Campos C; Claussen K; Christner M; Cramer JP; Haller H; Hornef M; Fickenscher H; Fraedrich K; Knobloch JK; Kühbacher T; Manns MP; Nitschke M; Peters G; Pulz M; Rohde H; Roseland RT; Sayk F; Schaumburg F; Schöcklmann HO; Schubert S; Solbach W; Karch H; Suerbaum S
    Clin Infect Dis; 2013 Apr; 56(8):1132-40. PubMed ID: 23300241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome.
    Page AV; Liles WC
    Med Clin North Am; 2013 Jul; 97(4):681-95, xi. PubMed ID: 23809720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of age and sex with the clinical outcome and incubation period of Shiga toxin-producing Escherichia coli O104:H4 infections, 2011.
    Werber D; King LA; Müller L; Follin P; Buchholz U; Bernard H; Rosner B; Ethelberg S; de Valk H; Höhle M
    Am J Epidemiol; 2013 Sep; 178(6):984-92. PubMed ID: 23935124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011.
    King LA; Nogareda F; Weill FX; Mariani-Kurkdjian P; Loukiadis E; Gault G; Jourdan-DaSilva N; Bingen E; Macé M; Thevenot D; Ong N; Castor C; Noël H; Van Cauteren D; Charron M; Vaillant V; Aldabe B; Goulet V; Delmas G; Couturier E; Le Strat Y; Combe C; Delmas Y; Terrier F; Vendrely B; Rolland P; de Valk H
    Clin Infect Dis; 2012 Jun; 54(11):1588-94. PubMed ID: 22460976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.
    Magnus T; Röther J; Simova O; Meier-Cillien M; Repenthin J; Möller F; Gbadamosi J; Panzer U; Wengenroth M; Hagel C; Kluge S; Stahl RK; Wegscheider K; Urban P; Eckert B; Glatzel M; Fiehler J; Gerloff C
    Brain; 2012 Jun; 135(Pt 6):1850-9. PubMed ID: 22539260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.
    Wu CJ; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):390-3. PubMed ID: 21862425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic ischaemia as a severe Shiga toxin/verotoxin producing Escherichia coli O104:H4 complication in a patient without haemolytic uraemic syndrome, Germany, June 2011.
    Cordesmeyer S; Peitz U; Gödde N; Kasper HU; Hoffmann MW; Allemeyer E
    Euro Surveill; 2011 Jun; 16(25):. PubMed ID: 21722614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.
    Greinacher A; Friesecke S; Abel P; Dressel A; Stracke S; Fiene M; Ernst F; Selleng K; Weissenborn K; Schmidt BM; Schiffer M; Felix SB; Lerch MM; Kielstein JT; Mayerle J
    Lancet; 2011 Sep; 378(9797):1166-73. PubMed ID: 21890192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde Trafficking Inhibitor of Shiga Toxins Reduces Morbidity and Mortality of Mice Infected with Enterohemorrhagic Escherichia coli.
    Secher T; Shima A; Hinsinger K; Cintrat JC; Johannes L; Barbier J; Gillet D; Oswald E
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5010-3. PubMed ID: 25987610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.
    Geerdes-Fenge HF; Löbermann M; Nürnberg M; Fritzsche C; Koball S; Henschel J; Höhn R; Schober HC; Mitzner S; Podbielski A; Reisinger EC
    Infection; 2013 Jun; 41(3):669-73. PubMed ID: 23292662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterohemorrhagic E. coli and hemolytic uremic syndrome in Georgia.
    Vashakidze E; Megrelishvili T; Pachkoria E; Tevzadze L; Lashkarashvili M
    Georgian Med News; 2010 Sep; (186):38-41. PubMed ID: 20972274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.
    Zimmerhackl LB; Rosales A; Hofer J; Riedl M; Jungraithmayr T; Mellmann A; Bielaszewska M; Karch H
    Semin Thromb Hemost; 2010 Sep; 36(6):586-93. PubMed ID: 20865635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
    Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
    Mahon BE; Griffin PM; Mead PS; Tauxe RV
    Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults.
    Weissenborn K; Donnerstag F; Kielstein JT; Heeren M; Worthmann H; Hecker H; Schmitt R; Schiffer M; Pasedag T; Schuppner R; Tryc AB; Raab P; Hartmann H; Ding XQ; Hafer C; Menne J; Schmidt BM; Bültmann E; Haller H; Dengler R; Lanfermann H; Giesemann AM
    Neurology; 2012 Oct; 79(14):1466-73. PubMed ID: 22993286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.